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 Aims—To examine among Hispanics in the U.S., a population with increased reliance on 
informal healthcare support structures, 1) the association between cognitive function and control 
of diabetes; and 2) whether this association is modified by family support.
 Methods—The Digit Symbol Substitution Test (DSST), Word Fluency, and learning and 
delayed recall components of the Spanish English Verbal Learning Test were administered to 
1,794 Hispanic adults aged 45–76 years with diagnosed diabetes. An executive function index and 
global cognitive function index (GCFI) were derived. Uncontrolled diabetes (HbA1c≥7% [53 
mmol/mol]) was compared across quartiles of cognitive function using multivariable logit models 
with interaction terms for cognitive function and family support.
 Results—After adjustment, lower DSST scores were associated with uncontrolled diabetes 
(P=0.03). Family support modified the relationship between other measures of cognition and 
diabetes control (Pinteraction: 0.002 to 0.09). Among individuals with low family support, as 
cognitive function declined, the odds of uncontrolled diabetes increased (P-trend across quartiles 
of the GCFI, 0.015). Among those with low family support, persons in the lowest quartile of 
global cognitive function were more than twice as likely to have uncontrolled diabetes as those in 
the highest performing quartile (OR=2.31; 95% CI: 1.17, 4.55). There was no similar effect among 
those with high family support.
 Conclusions—Family support may buffer the negative association between low cognitive 
functioning and diabetes control in US Hispanics/Latinos. Educational programs targeted at family 
members of middle-age and older persons with diabetes regardless of neurocognitive status may 
help improve population-level glycemic control.
Keywords
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 1. Introduction
Both type 2 diabetes and cognitive decline are common problems in older adults [1,2] and 
both may disproportionally affect Hispanic individuals.[2–4] Type 2 diabetes is a risk factor 
for cognitive decline and dementia.[5–9] Cognitive problems, in turn, may make optimal 
glycemic self-control more difficult, potentially shifting the burden of care to others.[10,11]
Cognitive decline in older adults ranges from subtle executive dysfunction and memory 
difficulties to dementia.[1] Cross-sectional and longitudinal results from the Action to 
Control Cardiovascular Risk in Diabetes (ACCORD) trial revealed inverse associations 
between cognitive function and glycemic control.[12] In a separate urban clinic-based study 
of older adults with diabetes, executive dysfunction and memory impairment were 
independent predictors of inadequate glycemic control.[13] Further cross-sectional studies 
have also reported a link between cognitive function and control of diabetes.[14,15]
Taken together, prior studies suggest that cognitive dysfunction may interfere with diabetes 
self-management and that poor diabetes control may contribute to cognitive decline. 
Diabetes self-management tasks, including close attention to diet, exercise, medication 
administration, and glucose monitoring, are cognitively demanding.[11] Evidence also 
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suggests that family support improves diabetes control in older adults with impaired 
cognition. In the Health and Retirement Study (HRS) of over 1000 persons with self-
reported diabetes ages 50 years and older, respondents in the lowest quartile of cognitive 
scores with low levels of social support had significantly higher hemoglobin A1c (HbA1c) 
levels than those in the highest quartile of cognition or those with high social support.[15] 
Importantly, higher levels of family support ameliorated this association between cognitive 
impairment and glycemic control. A more recent study of mild cognitive dysfunction in a 
largely Hispanic urban population found no association with glycemic control, though it was 
noted by the authors that assistance from informal care givers could not be ruled out.[16] 
Indeed, family support may be especially relevant to health outcomes among Hispanic 
individuals,[17–19] and particularly important for the cognitively-demanding activity of 
diabetes self-care.
In this study we hypothesized that lower levels of memory, executive functioning, and 
overall cognitive function would be associated with poor glycemic control in community-
dwelling Hispanic/Latino adults with diabetes age 45 years and older. We also sought to 
examine whether these relationships were modified by family support.
 2. Subjects, Materials and Methods
 2.1 Study population and data collection
The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) is a population-
based study of 16,415 Hispanic adults age 18–74 years at recruitment living in 4 U.S. urban 
centers (Bronx, NY; Chicago, IL; Miami, FL; and San Diego, CA). Participants were 
recruited using a 2-stage area probability sample design, as detailed previously.[20,21] The 
household-level response rate was 33.5% and 41.7% of screened individuals were enrolled, 
representing 16,415 persons from 9,872 households. Of 2,007 adults age 45–74 years at 
enrollment who reported a previous diagnosis of diabetes and/or taking antidiabetic 
medications within four weeks prior to the baseline interview, the current study was limited 
to those for whom complete data were available with regard to glycemic control, cognitive 
function, family support, and educational attainment (n=1,794 or 89%).
The HCHS/SOL baseline examination was conducted between 2008 and 2011 by bilingual 
interviewers in either English or Spanish, including blood collection, questionnaires 
covering a comprehensive assortment of sociodemographic, medical, environmental and 
lifestyle components, and a cognitive battery administered to those age 45 years and older. 
This study was approved by the Institutional Review Boards at each participating institution 
and all subjects gave informed consent.
 2.2 Cognitive variables
The cognitive tests administered to HCHS/SOL participants have been previously described:
[22] 1) Spanish English Verbal Learning Test (SEVLT), 2) Word Fluency (WF) Test, and 3) 
Digit Symbol Substitution Test (DSST). All examiners were trained to a common 
proficiency level in the scoring and administration of cognitive measures; certification was 
required prior to test administration and audio-taped exams from each examiner, with 
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associated paper responses, were reviewed periodically by the Neurocognitive Reading 
Center to maintain certification throughout the examination period.[23]
The SEVLT is a measure of episodic verbal learning and memory constructed to be 
psychometrically equivalent in English and Spanish versions.[24] It consists of three 15-
word learning trials, a fourth interference trial; and a fifth recall trial. We analyzed two 
measures from the SEVLT: 1) the sum of the first 3 trials to represent “learning,” with a 
maximum of 45; and 2) the fifth trial, termed “delayed recall,” which represents retention of 
the previously learned material. Both learning and delayed recall components of the SEVLT 
have been previously judged as similarly discriminant of cognitive decline regardless of 
language of administration.[25] In the WF test, participants were asked to produce as many 
words as possible beginning with the letter F, then the letter A, in consecutive 1-minute 
trials.[26] Unique English and Spanish words were accepted. In the DSST, the participant 
has 90 seconds to transcribe numbers into symbols using a key that pairs each of the digits 
1–9 with a unique symbol.[27] The WF test and DSST were translated from English to 
Spanish and backtranslated from Spanish to English.[22]
A variety of methods have been used to assess executive function, tapping into the constructs 
of planning, attention control, cognitive flexibility, and verbal/nonverbal fluency.[28,29] Due 
to the complex, multi-construct nature of executive function, and based on prior research 
[29,30] supporting a latent variable approach to its measurement, we created an “executive 
function index” that was specified a priori by summing standardized scores ([individual 
value – mean value]/SD) from the DSST and WF. Though the DSST had traditionally been 
considered an index of processing speed, recent studies [31,32] have shown that DSST 
performance among older adults clearly involves inhibition, shifting and to a lesser extent 
updating, the three main components of executive function.[30] Preliminary internal 
consistency analyses of this executive function index yielded a satisfactory Cronbach’s alpha 
of 0.64 among HCHS/SOL participants age 45–76 years.
In addition, we created a global cognitive function index by summing standardized scores of 
DSST, WF, SEVLT learning, and SEVLT recall (alpha=0.77). The use of composite scores 
increases measurement precision and limits the impact of measurement error and 
confounding biases relating to any one test.[33] Composite scores may also reveal subtle 
cognitive deficits not apparent in a single test score [34] and have been shown to better track 
with disease-related cognitive decline than individual scores.[35,36] Quartile categorizations 
were created for each cognitive measure with the first quartile representing those with the 
lowest cognitive functioning.
 2.3 Diabetes-related variables
Participants were asked to bring in all prescribed and over-the-counter medications taken 
within the past 4 weeks with them to the clinic examination. Medications were then scanned 
or transcribed and compared with a master drug list drawn from multiple commercial 
databases to assign therapeutic classification codes according to the convention of Medi-
Span’s Master Drug Data Base (MDDB®, version 2, 2003). Those who reported not 
bringing in all current medications were followed up over the phone, with complete 
medications recorded for over 97% of participants. Therefore, participants taking insulin or 
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oral hypoglycemic agents (OHGAs), were included in this analysis. In addition, those who 
self-reported taking “high blood sugar or diabetes” medications in the last 4 weeks, and 
those reporting a previous doctor diagnosis of diabetes that was not restricted to pregnancy, 
were also included. Participants taking insulin were identified either through review of 
medications or by an affirmative response to the question, “Are you being treated with 
insulin?” Since those taking insulin alone or in combination with OHGA had a similar 
prevalence of uncontrolled diabetes, and because relatively few took insulin, we created a 
single insulin treatment group.
Duration of diabetes (in years) was calculated by subtracting the reported age of diagnosis 
from the age at clinic visit. To assess diabetes control, blood specimens were collected and 
processed according to a standardized protocol.[21] HbA1c was measured in EDTA whole 
blood using a Tosoh G7 HPLC Analyzer (Tosoh Bioscience, Inc., South San Francisco, CA). 
In a repeatability study of HCHS/SOL participants of all ages (n=57), there was high test-
retest reliability of HbA1c laboratory measures (r=0.96). Uncontrolled diabetes was defined 
as HbA1c ≥ 7% (53 mmol/mol).[37]
 2.4 Other covariates
The Social Network Index (SNI), first described by Cohen and colleagues,[38] is a 13-item 
questionnaire of the diversity and size of participants’ social networks, and is commonly 
used to assess the number of people with whom the respondent has regular contact (at least 
once every two weeks).[39] HCHS/SOL participants completed an abbreviated 7-item 
version of the SNI consisting exclusively of questions regarding ties within the family. In 
accordance with recommended scoring of the full version of the SNI (http://
www.psy.cmu.edu/~scohen/SNI.html), we summed item 2, “How many children do you see 
or talk to on the phone at least once every 2 weeks?” and item 7, “How many other relatives 
(other than your spouse, parents & children) do you feel close to?” and added 1 point if 
married or living with a partner, to approximate the number of non-parent relatives with 
close ties that could have provided support with diabetes management. Parents and parents-
in-law were presumed to not play a supportive role in diabetes management in this middle-
aged and older adult population. In bivariate and multivariable analyses, tertile cut-points 
were used to categorically classify levels of family support; a median split dichotomous 
variable was employed in interaction analyses to increase power.
Additional covariates considered were sex, age, educational attainment, health insurance 
status, field center, self-identified Hispanic/Latino background, depressive symptomology 
assessed with a 10-item version of the Center for Epidemiologic Studies Depression Scale 
(CESD-10),[40] language of cognitive test administration, and healthcare utilization as 
defined by the number of physician visits in the past 12 months. We also adjusted for body 
mass index (BMI; kg·m−2), as well as a history of cardiovascular disease (CVD), defined as 
self-report of a doctor-diagnosed previous stroke or heart attack, self-report of prior balloon 
angioplasty, stent or bypass surgery, or electrocardiographic indicative of previous 
myocardial infarction (MI). Lastly, an aggregate measure of physical disability from the 
participant’s perspective was derived from the Physical Component Score (PCS) of the 
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SF-12 Health Survey Version 2.0 (QualityMetric Inc., Lincoln, RI), with the lowest quartile 
defined as “poor physical functioning.”
 2.5 Statistical Analysis
In accordance with procedures standard to large population-based studies,[41] all reported 
values were non-response adjusted, trimmed, and calibrated by age, sex, and Hispanic/
Latino national background to the characteristics of each field center’s target population 
from the 2010 U.S. Census. All analyses also account for cluster sampling and the 
stratification in the sample selection. P-values corresponding to Wald F-statistics and 95% 
confidence intervals (CI) were computed based on variance estimates derived from Taylor 
series linearization to account for the complex sampling scheme. Analyses were performed 
using SAS version 9.3 (SAS Institute, Cary, NC) and SUDAAN release 11.0.1 (RTI 
International, Research Triangle Park, NC), and all statistical tests are two-sided with a level 
of significance of 5%.
The prevalence of uncontrolled diabetes was examined among subgroups defined by 
covariates of interest. Logistic regression models were constructed with uncontrolled 
diabetes (HbA1c ≥ 7% [53 mmol/mol]) as the outcome of interest and quartiles of cognitive 
function as independent variables. Analyses were adjusted for potential confounders defined 
a priori. Participants with missing values for any of the covariates were excluded from all 
models (7% excluded, yielding n=1,661). Odds ratios and 95% CIs are presented with the 
highest performing group (group 4) serving as the reference. We also present p-values for a 
trend over quartiles of cognitive function, derived from fully adjusted models in which 
cognitive scores grouped in quartiles were entered into models as continuous variables. 
Quartiles analyses are presented as primary to better capture the nature of associations with 
the outcome. However, models using continuous cognitive measures were run in parallel for 
increased power.
Interaction models were fully-adjusted and contained interaction terms between quartiles of 
cognitive function measures and family support. Odds ratios and 95% CIs were computed 
using a common referent group within each model (high cognitive function and low family 
support). P-values for the interaction between family support and cognitive variables were 
computed with cognitive function quartiles entered into the model as continuous variables. 
Additional interaction models were constructed to test for heterogeneity across subgroups of 
age (60 years or older versus 45–60 years), gender, and antidiabetic medication use (none 
versus OHGA only versus insulin). Lastly, two sensitivity analyses were carried out. First, 
analyses were repeated while excluding individuals not taking antidiabetic medications and 
therefore presumably managing their diabetes through lifestyle modification. Second, 
because language of test administration was previously related to cognitive test performance 
in the HCHS/SOL population[22] and to exclude any artifactual influence of test language 
on the results, we conducted parallel analyses in which the minority of participants who 
were given the tests in English (n=237; 13% of the sample) were excluded.
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 3. Results
Included were 1,794 HCHS/SOL participants age 45 years or older with a previous 
diagnosis of diabetes, after exclusion of 11% with missing data for key variables. Subjects 
were predominantly female, under 65 years of age, and most were taking OHGA but not 
insulin (Table 1). Correlates of uncontrolled diabetes were younger age, OHGA and insulin 
use, more time since diabetes diagnosis, and less frequent use of healthcare services. Study 
participants reported a median of 6 close relatives excluding parents and parents-in-law (data 
not shown).
Table 2 shows the relative odds for uncontrolled diabetes (HbA1c ≥ 7% [53 mmol/mol]) 
among those with varying levels of cognitive function. In fully adjusted models we observed 
higher odds of uncontrolled diabetes with lower scores on the DSST (P-for-trend=0.03). We 
did not observe an overall association with respect to the other cognitive tests. However, 
interaction analyses (Figure 1) suggested that family support modifies the association of 
cognitive test performance with glycemic control. Specifically, associations between poor 
cognitive function and glycemic control were present only among the low family support 
group. Among individuals with low family support (0–6 close family members), those with 
lower quartiles of cognition had higher odds of uncontrolled diabetes compared to those in 
the higher quartiles for each test (Ptrend between 0.006 and 0.14 for each cognitive score). 
Among those with low family support, we observed a monotonic increase in the odds of 
uncontrolled diabetes over decreasing quartiles of global cognitive function, with those in 
the lowest quartile having 2.31 times the odds of uncontrolled diabetes than those in the 
highest quartile (95% CI: 1.17, 4.55). Individuals with low family support and membership 
in group 1 (low performance) for executive function index, the measure with the largest 
observed effect magnitude, was associated with a nearly three-fold increased odds for 
uncontrolled diabetes (OR=2.92, 95% CI: 2.04, 8.53), when compared to those with low 
family support and high executive function (group 4). These associations were not observed 
in those with high family support. Interactions were statistically significant between family 
support and both word fluency and the executive function index (P<0.01), with trends for 
interaction with family support observed for the global cognitive function index (P=0.06), as 
well as SEVLT learning (P=0.09) and delayed recall (P=0.07).
We also examined the association between family support and glycemic control within 
categories of executive functioning. Among those with the lowest level of executive function 
(group 1), high family support was associated with a trend for lower odds of uncontrolled 
diabetes (versus low family support, OR: 0.58; 95% CI: 0.30, 1.10; P=0.09). However, 
among individuals with high executive functioning (group 4), high family support was 
associated with significantly higher odds of poor glycemic control (versus low family 
support, OR: 2.46; 95% CI: 1.40, 4.34).
Further analyses in which cognitive scores were coded as continuous did not materially alter 
the results (data not shown). In addition, we did not observe effect measure modification by 
medication use, age, or gender, across all measures of cognitive functioning treated as either 
categorical or continuous (data not shown). Further adjustment for language of cognitive test 
administration in multivariable models did not appreciably alter effect estimates and 
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sensitivity analyses excluding those who were administered the tests in English did not alter 
the results (data not shown). Of note, sensitivity analyses excluding participants previously 
diagnosed with diabetes but who were not taking OHGA or insulin within 4 months prior to 
the clinic visit yielded qualitatively similar results with somewhat increased magnitude of 
effect (data not shown). Results presented here included these individuals in order to avoid 
biases related to selective inclusion of those receiving medications.
 4. Discussion
A cross-sectional analysis of diabetes control in community-dwelling Hispanic/Latino adults 
revealed complex relationships among cognitive function, family support, and glycemic 
control. We found that low levels of both a composite global cognitive function index and an 
index containing measures thought to represent executive functioning were both associated 
with increased odds of uncontrolled diabetes, but only among those with low family support. 
Statistically significant interaction or trends toward interaction with family support were 
consistent across multiple measures of cognitive functioning. In addition, while family 
support was not associated with glycemic control in the aggregate, there was a trend toward 
a protective association in those with low levels of executive functioning and a detrimental 
effect in those with high executive functioning.
Okura, et al. found a similar support-dependent association between cognitive functioning 
and glycemic control among the HRS participants with diabetes, suggesting social support 
may buffer the effect of cognitive function on glycemic control.[15] The present study lends 
support to a buffering role of social networks, and extends this finding to U.S. Hispanics 
with diabetes.
The relationship between type 2 diabetes prevalence and onset of cognitive impairment or 
dementia is well-established in prospective observational studies.[7,42] Additionally, 
evidence suggests that better cognition is associated with improved diabetes management. In 
one prospective study,[6] DSST was associated with diabetes control, a finding consistent 
with DSST results presented here. We speculate that the consistent association shown here 
and in previous analyses of diabetes control with DSST, but not with other cognitive 
measures when considered individually, may be representative of DSST performance as a 
measure involving multiple neuropsychological domains including attention, psychomotor 
speed, and executive function.[43]
Several cross-sectional studies have found that better cognitive function in persons with 
diabetes is associated with control of HbA1c.[12–15] A strong dose-dependent association 
was observed between glycemic control and executive function in an urban clinic-based 
study, as well as increased odds of inadequate control among patients with memory 
impairment.[13] In light of this finding, the lack of an effect of memory in the present study 
was unexpected. However, the older age and higher prevalence of co-morbid disease in the 
previous study, and the use of different cognitive tests may have contributed to the observed 
differences. Indeed, several of the cross-sectional studies finding an effect between cognitive 
function and diabetes control were conducted in older populations.[12,14,15]
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A more recent prospective analysis of a largely Hispanic sample of elderly adults with 
diabetes failed to observe an effect of mild cognitive dysfunction on diabetes control, 
pointing to other contextual factors such as the social environment that could moderate the 
effect of cognitive decline on diabetes management.[16] The present study illustrates the 
importance of considering family support in such studies. Informal support with diabetes 
self-care may be of particular importance for older Hispanics/Latinos with diabetes. 
Findings presented here suggest that large family networks may buffer the effect of cognitive 
decline on impairment of diabetes control that has been observed in other populations.
Strengths of our study include the large population-based sampling design of HCHS/SOL 
allowing adequate control of several potential confounders and the uniform assessment of 
cognitive measures. However, there are some limitations, most notable being the nature of 
our family support measure. Hispanic individuals are generally believed to have closer ties 
with extended families than some other ethnic groups, which may have accentuated both the 
benefits and costs of large family networks. Our finding among individuals in the lowest 
quartile for some measures of cognitive function, in which increased family support tended 
to be associated with uncontrolled diabetes, likely reflects the quantitative rather than 
qualitative nature of our measure. We did not measure whether family members actually 
supported diabetes care. Broadhead and colleagues posit that an increase in social contacts 
may produce increased demands for reciprocal support and therefore have a detrimental 
impact on health in some settings.[44] The observation of this phenomenon in the present 
context highlights the fact that family members may be a burden on self-sustaining older 
adults with diabetes, and that efforts should be made to educate family members, regardless 
of mental and physical comorbidities of the patient.
Secondly, the relatively low household-level response rate in the study may have resulted in 
selection biases related to diabetes status, cognitive functioning, and family support. 
However, HCHS/SOL study employed a probability sampling design. Even though the 
response rate is not optimal, a widely accepted statistical adjustment protocol was followed 
to reduce the potential bias of effect estimates due to study non-participation.
Finally, the cross sectional design of the study precludes conclusions about the causal 
direction of the association between glycemic control and cognition. One case-control study 
found that mild cognitive impairment was associated with increased duration and severity of 
diabetes,[5] implying that increased exposure to unregulated glucose levels leads to 
cognitive impairment. Several biological mechanisms have been proposed to support this 
argument.[42,45] On the other hand, individuals with diabetes who have evidence of 
cognitive impairment are significantly less likely to be involved in diabetes self-care and 
diabetes monitoring.[46] If self-care is the only option due to lack of family support and 
access to healthcare resources, then cognitive dysfunction could lead to inadequate control. 
This may be particularly true in Hispanics/Latinos, a population with an increased reliance 
on informal healthcare support structures.[18,19] The buffering role of family connections in 
the present study supports this view.
Further work is necessary to understand the causal relationships between glycemic control, 
cognitive function, and family support among middle-aged and older Hispanics/Latinos. Our 
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findings suggest that targeting diabetes control resources to individuals with low cognitive 
functioning and education programs aimed at family members of middle-aged and older 
adults with diabetes may help improve glycemic control in the population.
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Figure 1. 
Cognitive function, family support and uncontrolled diabetes among Hispanics/Latinos over 
age 45-years with diagnosed diabetes, 2008–2011 (n=1,661). P-trend values test for a 
significant linear trend in the outcome across quartiles of cognitive dysfunction, within 
family support strata; models were adjusted for Hispanic/Latino national background, field 
center, education, age, and gender, health insurance status, oral hypoglycemic agent and 
insulin use, years since diabetes diagnosis, family support, depression, healthcare utilization 
in the past year, poor physical functioning, prevalent cardiovascular disease, and body mass 
index (BMI; kg·m−2).
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Abbreviations: DSST, Digit Symbol Substitution Test; HbA1c, glycosylated hemoglobin; 
OR, odds ratio; SEVLT, Spanish English Verbal Learning Test
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Table 2
Level of neurocognitive function and relative odds of uncontrolled diabetes: Results from multivariable 
logistic regression a
Neurocognitive function quartile, range b n OR for having HbA1c≥7% [53 mmol/mol] (95% CI) P P-trend
Global cognitive function index
 Quartile 4, [3.03, 11.3] (best function) 413 1 (ref) 0.08
 Quartile 3, [0.26, 3.03) 418 1.19 (0.78, 1.81) 0.43
 Quartile 2, [−2.35, 0.26) 421 1.51 (0.94, 2.42) 0.09
 Quartile 1, [−11.2, −2.35) 409 1.54 (0.90, 2.64) 0.12
Executive function index
 Quartile 4, (1.51, 6.92] 411 1 (ref) 0.24
 Quartile 3, [−0.03, 1.51] 427 1.49 (0.98, 2.26) 0.06
 Quartile 2, [−1.56, −0.04] 420 1.45 (0.85, 2.47) 0.18
 Quartile 1, [−5.9, −1.56) 403 1.43 (0.82, 2.53) 0.21
Digit Symbol Substitution Test
 Quartile 4, [39,81] 453 1 (ref) 0.03
 Quartile 3, [30,38] 385 1.19 (0.81, 1.76) 0.37
 Quartile 2, [21,29] 444 1.74 (1.06, 2.88) 0.03
 Quartile 1, [0,20] 379 1.62 (0.93, 2.81) 0.09
Word fluency
 Quartile 4, [22,40] 437 1 (ref) 0.51
 Quartile 3, [17,21] 414 0.64 (0.42, 0.97) 0.04
 Quartile 2, [12,16] 439 1.08 (0.68, 1.71) 0.74
 Quartile 1, [0,11] 371 0.72 (0.42, 1.21) 0.21
SEVLT learning
 Quartile 4, [26, 37] 432 1 (ref) 0.33
 Quartile 3, [22, 25] 444 0.99 (0.64, 1.53) 0.97
 Quartile 2, [18, 21] 416 1.33 (0.89, 1.99) 0.17
 Quartile 1, [3, 17] 369 1.21 (0.76, 1.92) 0.43
SEVLT delayed recall
 Quartile 4, [10, 15] 505 1 (ref) 0.69
 Quartile 3, [8, 9] 466 1.18 (0.79, 1.78) 0.41
 Quartile 2, [6, 7] 371 1.30 (0.84, 2.01) 0.24
 Quartile 1, [0, 5] 319 1.09 (0.70, 1.71) 0.69
aUncontrolled diabetes defined as HbA1c ≥ 7% (53 mmol/mol); those with missing covariates excluded from all analyses; models adjusted for 
Hispanic/Latino national background, field center, education, age, and gender, health insurance status, oral hypoglycemic agent and insulin use, 
years since diabetes diagnosis, family support, depression, healthcare utilization in the past year, poor physical functioning, prevalent 
cardiovascular disease, and body mass index
bGroup 4, with higher levels of learning, memory, or executive function, served as the reference
Abbreviations: HbA1c, glycosylated hemoglobin; SEVLT, Spanish English Verbal Learning Test
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